Gary Kaplan | Profiles RNS

Gary B. Kaplan, MD

Emeritus Professo

Boston University Chobanian & Avedisian School of Medicine

Psychiatry

General Psychiatry

MD, Hahnemann University
BA, University of Pennsylvania

Websites

	Gary B. Kaplan Laboratory
	Neuroscience Faculty
	LinkedIn
	ResearchGate

Dr. Kaplan serves as the Director of the Mental Health Service and Chief of Psychiatry at VA Boston Healthcare System. His clinical and pre-clinical and research focus is within the neurobiology and neuropharmacology of addiction, schizophrenia, and conditioned fear. His research specifically examines conditioned drug reward and its extinction and is published in journals of neuroscience and pharmacology.

Dr. Kaplan currently serves on the editorial board the Journal of Clinical Pharmacology. His national role in psychiatry has been recognized by the American Psychiatric Association where he was conferred as a Distinguished Fellow. He is the lead author of a text for the American Psychiatric Press Inc. for psychiatric clinicians and residents entitled Brain Circuitry and Signaling in Psychiatry which examines the functional circuitry and neurochemical pathways in psychiatric illnesses.

Dr. Kaplan is a graduate of University of Pennsylvania and Drexel University College of Medicine (Hahnemann). His residency training in Psychiatry and post-doctoral research training in Pharmacology were at Tufts University School of Medicine.

Professor
Boston University Chobanian & Avedisian School of Medicine
Pharmacology, Physiology & Biophysics

VA Boston Healthcare System

Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

BU Research
NIH RePORTER Research

Incentives Plus Bupropion for Smoking in Schizophrenics
07/01/2005 - 06/30/2007 (PI)
Brown University NIH NIDA

Title

Yr	Title	Project-Sub Proj	Pubs
2022	Treatment of Sleep Disturbances in TBI with Orexin Receptor Antagonist	5I21RX003722-02
2021	Treatment of Sleep Disturbances in TBI with Orexin Receptor Antagonist	1I21RX003722-01
2020	Behavioral and Neural Plasticity in TBI and PTSD	5I01RX001144-06	1
2020	Behavioral and Neural Plasticity in TBI and PTSD	5I01RX001144-05	1
2018	Behavioral and Neural Plasticity in TBI and PTSD	5I01RX001144-04	1
2017	Behavioral and Neural Plasticity in TBI and PTSD	5I01RX001144-02	1
2017	Behavioral and Neural Plasticity in TBI and PTSD	5I01RX001144-03	1
2015	Behavioral and Neural Plasticity in TBI and PTSD	1I01RX001144-01A2	1
2014	Therapeutic Approaches for Extinction of Conditioned Drug Reward	5I01BX000814-04
2014	Neurotrophic factor mechanisms in treatments in TBI and PTSD	5I01RX000361-02	1

Showing 10 of 14 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Kaplan GB, Thompson BL. Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence. Front Pharmacol. 2023; 14:1253736. PMID: 38044942; PMCID: PMC10690374; DOI: 10.3389/fphar.2023.1253736;

Babb JA, Constantino NJ, Kaplan GB, Chartoff EH. Estrous cycle dependent expression of oxycodone conditioned reward in rats. Sci Rep. 2023 Aug 25; 13(1):13946. PMID: 37626154; PMCID: PMC10457365; DOI: 10.1038/s41598-023-40971-3;

Babb JA, Zuberer A, Heinrichs S, Rumbika KK, Alfiler L, Lakis GA, Leite-Morris KA, Kaplan GB. Disturbances in fear extinction learning after mild traumatic brain injury in mice are accompanied by alterations in dendritic plasticity in the medial prefrontal cortex and basolateral nucleus of the amygdala. Brain Res Bull. 2023 Jun 15; 198:15-26.View Related Profiles.

Zuberer, Agnieszka
Kaplan, Gary
Leite-Morris, Kimberly

PMID: 37031792

Kaplan GB, Dadhi NA, Whitaker CS. Mitochondrial dysfunction in animal models of PTSD: Relationships between behavioral models, neural regions, and cellular maladaptation. Front Physiol. 2023; 14:1105839. PMID: 36923289; PMCID: PMC10009692; DOI: 10.3389/fphys.2023.1105839;

Brown RE, Kaplan GB. Introduction to special issue: Sleep and arousal in health and disease. Brain Res Bull. 2022 Oct 01; 188:131-132. PMID: 35918033; PMCID: PMC9903342; DOI: 10.1016/j.brainresbull.2022.07.021;

Kaplan GB, Lakis GA, Zhoba H. Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems. Brain Res Bull. 2022 Aug; 186:106-122. PMID: 35618150

Brown RE, Spratt TJ, Kaplan GB. Translational approaches to influence sleep and arousal. Brain Res Bull. 2022 Jul; 185:140-161. PMID: 35550156; PMCID: PMC9554922; DOI: 10.1016/j.brainresbull.2022.05.002;

Liverant GI, Gallagher MW, Arditte Hall KA, Rosebrock LE, Black SK, Kind S, Fava M, Kaplan GB, Kamholz BW, Pineles SL, Sloan DM. Suppression and acceptance in unipolar depression: Short-term and long-term effects on emotional responding. Br J Clin Psychol. 2022 Mar; 61(1):1-17.View Related Profiles.

Kamholz, Barbara
Sloan, Denise
Kaplan, Gary
Black, Shimrit
Pineles, Suzanne

PMID: 34268773

Thompson BL, Oscar-Berman M, Kaplan GB. Opioid-induced structural and functional plasticity of medium-spiny neurons in the nucleus accumbens. Neurosci Biobehav Rev. 2021 01; 120:417-430.View Related Profiles.

Thompson, Benjamin
Kaplan, Gary

PMID: 33152423; PMCID: PMC7855607; DOI: 10.1016/j.neubiorev.2020.10.015;

Kaplan GB, Leite-Morris KA, Wang L, Rumbika KK, Heinrichs SC, Zeng X, Wu L, Arena DT, Teng YD. Pathophysiological Bases of Comorbidity: Traumatic Brain Injury and Post-Traumatic Stress Disorder. J Neurotrauma. 2018 01 15; 35(2):210-225.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 29017388

Showing 10 of 72 results. Show More

Kobrin KL, Arena DT, Heinrichs SC, Nguyen OH, Kaplan GB. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core. Behav Brain Res. 2017 03 30; 322(Pt A):18-28.View Related Profiles.

Kaplan, Gary
Kobrin, Kendra
Nguyen, Olivia

PMID: 28089852; DOI: 10.1016/j.bbr.2017.01.011;

Kobrin KL, Moody O, Arena DT, Moore CF, Heinrichs SC, Kaplan GB. Acquisition of morphine conditioned place preference increases the dendritic complexity of nucleus accumbens core neurons. Addict Biol. 2016 Nov; 21(6):1086-1096.View Related Profiles.

Moore, Catherine
Kaplan, Gary
Kobrin, Kendra

PMID: 26096355; DOI: 10.1111/adb.12273;

Liverant GI, Sloan DM, Pizzagalli DA, Harte CB, Kamholz BW, Rosebrock LE, Cohen AL, Fava M, Kaplan GB. Associations among smoking, anhedonia, and reward learning in depression. Behav Ther. 2014 Sep; 45(5):651-63.View Related Profiles.

Kamholz, Barbara
Harte, Christopher
Sloan, Denise
Kaplan, Gary

PMID: 25022776; PMCID: PMC4446716; DOI: 10.1016/j.beth.2014.02.004;

Leite-Morris KA, Kobrin KL, Guy MD, Young AJ, Heinrichs SC, Kaplan GB. Extinction of opiate reward reduces dendritic arborization and c-Fos expression in the nucleus accumbens core. Behav Brain Res. 2014 Apr 15; 263:51-9.View Related Profiles.

Kaplan, Gary
Kobrin, Kendra
Leite-Morris, Kimberly
Guy, Marsha

PMID: 24406724; DOI: 10.1016/j.bbr.2013.12.041;

Harte CB, Liverant GI, Sloan DM, Kamholz BW, Rosebrock LE, Fava M, Kaplan GB. Association between smoking and heart rate variability among individuals with depression. Ann Behav Med. 2013 Aug; 46(1):73-80.View Related Profiles.

Kamholz, Barbara
Harte, Christopher
Sloan, Denise
Kaplan, Gary

PMID: 23436273; DOI: 10.1007/s12160-013-9476-8;

Heinrichs SC, Leite-Morris KA, Rasmusson AM, Kaplan GB. Repeated valproate treatment facilitates fear extinction under specific stimulus conditions. Neurosci Lett. 2013 Sep 27; 552:108-13.View Related Profiles.

Rasmusson, Ann
Kaplan, Gary
Leite-Morris, Kimberly

PMID: 23916657; DOI: 10.1016/j.neulet.2013.07.035;

Heinrichs SC, Leite-Morris KA, Guy MD, Goldberg LR, Young AJ, Kaplan GB. Dendritic structural plasticity in the basolateral amygdala after fear conditioning and its extinction in mice. Behav Brain Res. 2013 Jul 1; 248:80-4.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly
Goldberg, Lisa
Guy, Marsha

PMID: 23570859; PMCID: PMC4438560; DOI: 10.1016/j.bbr.2013.03.048;

Nic Dhonnchadha BÁ, Lin A, Leite-Morris KA, Kaplan GB, Man HY, Kantak KM. Alterations in expression and phosphorylation of GluA1 receptors following cocaine-cue extinction learning. Behav Brain Res. 2013 Feb 1; 238:119-23.View Related Profiles.

Kaplan, Gary
Kantak, Kathleen
Leite-Morris, Kimberly

PMID: 23085477; PMCID: PMC3542979; DOI: 10.1016/j.bbr.2012.10.012;

Nic Dhonnchadha BÁ, Lovascio BF, Shrestha N, Lin A, Leite-Morris KA, Man HY, Kaplan GB, Kantak KM. Changes in expression of c-Fos protein following cocaine-cue extinction learning. Behav Brain Res. 2012 Sep 1; 234(1):100-6.View Related Profiles.

Kaplan, Gary
Kantak, Kathleen
Leite-Morris, Kimberly

PMID: 22721675; PMCID: PMC3412160; DOI: 10.1016/j.bbr.2012.06.010;

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 2013 Jan; 15(1):121-9. PMID: 22517190; PMCID: PMC3524060; DOI: 10.1093/ntr/nts098;

Ahnallen CG, Liverant GI, Gregor KL, Kamholz BW, Levitt JJ, Gulliver SB, Pizzagalli DA, Koneru VK, Kaplan GB. The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. Psychiatry Res. 2012 Mar 30; 196(1):9-14.View Related Profiles.

Kamholz, Barbara
Kaplan, Gary
Gregor, Kristin
Gulliver, Suzy

PMID: 22342123; PMCID: PMC3351530; DOI: 10.1016/j.psychres.2011.09.011;

Kaplan GB, Young AJ, Guy MD, Leite-Morris K. Biological Psychiatry. Extinction of Fear Conditioning is Associated with Changes in Prefrontal Cortical Spine Morphology in Mice. 2012.

Kaplan GB, Leite-Morris KA, Fan W, Young AJ, Guy MD. Opiate sensitization induces FosB/?FosB expression in prefrontal cortical, striatal and amygdala brain regions. PLoS One. 2011; 6(8):e23574.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly
Guy, Marsha

PMID: 21886798; PMCID: PMC3160315; DOI: 10.1371/journal.pone.0023574;

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl). 2011 Sep; 217(2):279-87. PMID: 21475970; PMCID: PMC3685403; DOI: 10.1007/s00213-011-2282-8;

Kaplan GB, Moore KA. The use of cognitive enhancers in animal models of fear extinction. Pharmacol Biochem Behav. 2011 Aug; 99(2):217-28. PMID: 21256147; DOI: 10.1016/j.pbb.2011.01.009;

Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behav Pharmacol. 2010 Sep; 21(5-6):427-37.View Related Profiles.

Kaplan, Gary
Vasterling, Jennifer

PMID: 20679891; DOI: 10.1097/FBP.0b013e32833d8bc9;

Kaplan GB, Heinrichs SC, Carey RJ. Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications. Pharmacol Biochem Behav. 2011 Jan; 97(3):619-25. PMID: 20723558; DOI: 10.1016/j.pbb.2010.08.004;

Sirota AD, Rohsenow DJ, Mackinnon SV, Martin RA, Eaton CA, Kaplan GB, Monti PM, Tidey JW, Swift RM. Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addict Behav. 2010 Jul; 35(7):686-93. PMID: 20381260; PMCID: PMC3746812; DOI: 10.1016/j.addbeh.2010.02.014;

Heinrichs SC, Leite-Morris KA, Carey RJ, Kaplan GB. Baclofen enhances extinction of opiate conditioned place preference. Behav Brain Res. 2010 Mar 5; 207(2):353-9.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 19840820; DOI: 10.1016/j.bbr.2009.10.013;

Kaplan GB. Fear Conditioning Effects on Sensitivity to Drug Reward. 2009.

Kaplan GB, Leite-Morris KA, Klufas MA, Fan W. Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity. Eur J Pharmacol. 2009 Jan 14; 602(2-3):268-76.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 19027733; DOI: 10.1016/j.ejphar.2008.10.052;

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Adolfo AB. Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res. 2008 Jun; 10(6):1047-56. PMID: 18584468; PMCID: PMC2952171; DOI: 10.1080/14622200802097373;

Krystal JH, Gueorguieva R, Cramer J, Collins J, Rosenheck R. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism". Alcohol Clin Exp Res. 2008 Jan; 32(1):85-91. PMID: 18070245; DOI: 10.1111/j.1530-0277.2007.00555.x;

Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res. 2007 Apr; 31(4):555-63.View Related Profiles.

Kaplan, Gary
Zhang, Huiping

PMID: 17374034; DOI: 10.1111/j.1530-0277.2007.00339.x;

Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol. 2007 Feb; 15(1):81-92. PMID: 17295587

Kaplan GB, Phillips KA, Vaccaro A, Eisen JL, Posternak MA, MacAskill HS. Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale. Schizophr Res. 2006 Feb 28; 82(2-3):279-81. PMID: 16406495; PMCID: PMC1626389; DOI: 10.1016/j.schres.2005.11.009;

Epstein-Lubow G, Hochstadt J, Lieberman P, Kaplan GB. Speech production in schizophrenia: preliminary data regarding voice onset time. Schizophr Res. 2006 Feb 28; 82(2-3):267-9. PMID: 16371248

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend. 2005 Nov 1; 80(2):259-65. PMID: 15869844

Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine Tob Res. 2005 Jun; 7(3):421-9. PMID: 16085510

Kaplan GB, McRoberts RL, Smokler HJ. Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder. J Clin Psychopharmacol. 2004 Oct; 24(5):574-5. PMID: 15349029

Kranzler HR, Wesson DR, Billot L. Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res. 2004 Jul; 28(7):1051-9. PMID: 15252291

Turalba AV, Leite-Morris KA, Kaplan GB. Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice. Neurosci Lett. 2004 Feb 26; 357(1):53-7.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 15036612

Leite-Morris KA, Fukudome EY, Shoeb MH, Kaplan GB. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. J Pharmacol Exp Ther. 2004 Feb; 308(2):667-78.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 14610238

Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res. 2003 Oct 10; 987(1):122-5.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 14499954

Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003 Sep-Oct; 6(5):566-73. PMID: 14627063

Leite-Morris KA, Fukudome EY, Kaplan GB. Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neurosci Lett. 2002 Jan 14; 317(3):119-22.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 11755254

Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA. Naltrexone in the treatment of alcohol dependence. N Engl J Med. 2001 Dec 13; 345(24):1734-9. PMID: 11742047; DOI: 10.1056/NEJMoa011127;

Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol. 2000 Nov; 109(4):738-42. PMID: 11195999

Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2000 Sep; 2(3 Pt 2):249-55. PMID: 11249802

Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam. J Clin Psychopharmacol. 2000 Jun; 20(3):338-46. PMID: 10831021

Kaplan GB, Leite-Morris KA, Keith DJ. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins. Neurosci Lett. 1999 Oct 8; 273(3):147-50.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 10515180

Kaplan GB, Bharmal NH, Leite-Morris KA, Adams WR. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol. 1999 Oct; 19(2):157-62.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 10548160

Weisberg SP, Kaplan GB. Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse. Neurosci Lett. 1999 Apr 2; 264(1-3):89-92. PMID: 10320021

Kaplan GB, Coyle TS. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur J Pharmacol. 1998 Nov 27; 362(1):1-8. PMID: 9865523

Leite-Morris KA, Kaplan GB, Smith JG, Sears MT. Regulation of G proteins and adenylyl cyclase in brain regions of caffeine-tolerant and -dependent mice. Brain Res. 1998 Aug 31; 804(1):52-62.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 9729274

Kaplan GB, Sethi RK, McClelland EG, Leite-Morris KA. Regulation of G protein-mediated adenylyl cyclase in striatum and cortex of opiate-dependent and opiate withdrawing mice. Brain Res. 1998 Mar 30; 788(1-2):104-10.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 9554971

Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects. J Clin Pharmacol. 1998 Jan; 38(1):14-21. PMID: 9597554

Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997 Aug; 37(8):693-703. PMID: 9378841

Kaplan GB, Leite-Morris KA. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Res. 1997 Jul 25; 763(2):215-20.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 9296562

Kaplan GB, Sears MT. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology (Berl). 1996 Jan; 123(1):64-70. PMID: 8741956

Kaplan GB, Leite-Morris KA, Sears MT. Alterations of adenosine A1 receptors in morphine dependence. Brain Res. 1994 Sep 19; 657(1-2):347-50.View Related Profiles.

Kaplan, Gary
Leite-Morris, Kimberly

PMID: 7820640

Kaplan GB, Greenblatt DJ, Kent MA, Cotreau-Bibbo MM. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. J Pharmacol Exp Ther. 1993 Sep; 266(3):1563-72. PMID: 8371158

Kaplan GB, Cotreau MM, Greenblatt DJ. Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo. J Pharm Pharmacol. 1992 Aug; 44(8):700-3. PMID: 1359103

Kaplan GB, Greenblatt DJ, Kent MA, Cotreau MM, Arcelin G, Shader RI. Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy. Neuropsychopharmacology. 1992 May; 6(3):145-53. PMID: 1599605

Kaplan GB. Neurobiological aspects of panic disorder. R I Med. 1992 May; 75(5):247-51. PMID: 1351409

Kaplan GB, Tai NT, Greenblatt DJ, Shader RI. Caffeine-induced behavioural stimulation is dose- and concentration-dependent. Br J Pharmacol. 1990 Jul; 100(3):435-40. PMID: 2390669; PMCID: PMC1917803

Kaplan GB, Tai NT, Greenblatt DJ, Shader RI. Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo. Psychopharmacology (Berl). 1990; 101(4):539-44. PMID: 2167493

Lopez F, Miller LG, Greenblatt DJ, Kaplan GB, Shader RI. Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding. Eur J Pharmacol. 1989 Dec 5; 172(6):453-9. PMID: 2482188

Kaplan GB, Greenblatt DJ, Leduc BW, Thompson ML, Shader RI. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity. J Pharmacol Exp Ther. 1989 Mar; 248(3):1078-83. PMID: 2539455

Kaplan GB. Human Psychopharmacology: Measures and Methods, Vol. 2. I. Journal of Clinical Psychopharmacology. 1989; 9(6). View Publication

Arana GW, Kaplan GB. Trazodone-induced mania following desipramine-induced mania in major depressive disorders. Am J Psychiatry. 1985 Mar; 142(3):386. PMID: 3970283

Clark CC, Crossland J, Kaplan G, Martinez-Hernandez A. Location and identification of the collagen found in the 14.5-d rat embryo visceral yolk sac. J Cell Biol. 1982 May; 93(2):251-60. PMID: 7096438; PMCID: PMC2112863

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 72 publications over 32 distinct years, with a maximum of 5 publications in 2012

Bar chart showing 72 publications over 32 distinct years, with a maximum of 5 publications in 2012

Year	Publications
1982	1
1985	1
1989	3
1990	2
1992	3
1993	1
1994	1
1996	1
1997	2
1998	4
1999	3
2000	3
2001	1
2002	1
2003	3
2004	3
2005	3
2006	1
2007	3
2008	2
2009	2
2010	3
2011	3
2012	5
2013	3
2014	2
2015	1
2017	2
2020	1
2021	1
2022	3
2023	4

2016 VA Boston Healthcare System: Healthcare for Homeless Veterans Appreciation Award

2013 VA Boston Healthcare System: Special Contribution Award

2008-2013 Marquis: Who’s Who in America

2008-2009 VA Boston Healthcare System: Special Contribution Award

2007-2017 American Psychiatric Association : Distinguished Fellow

2007-2016 Best Doctors in America

2005 Veterans Affairs Medical Center- Providence: Director’s Commendation

2003 Department of Psychiatry & Human Behavior, Brown Medical School: Mentorship Award

2001 Department of Psychiatry & Human Behavior, Brown Medical School: Medical Student Teaching Award

2001 Brown University: Masters of Arts (Ad Eundem)

2000 Rhode Island Disabled American Veterans : Physician of the Year Award

1998 Veterans Affairs Medical Center- Providence: Special Contribution Award

1998-1999 Society for Royce Fellows, Brown University: Mentor

1996 Department of Psychiatry & Human Behavior, Brown Medical School: Research Award

1993 Department of Psychiatry & Human Behavior, Brown Medical School: Research Award

Contact for Mentoring:

150 S Huntington Ave
Jamaica Plain MA 02130
Google Map

774.826.2473

Download vCard

Kaplan's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (311) concept(s)

Co-Authors

See all (13) people

Similar People

See all (60) people

Same Department

Search Department